Lonza Group Ltd.

About Lonza Group Ltd.

Lonza Group manufactures and supplies active pharmaceutical ingredients, biologics, cell and gene therapies, microbiome therapeutics, and specialty chemicals for the pharmaceutical, biotech, nutrition, and consumer care markets. Headquartered in Basel, Switzerland, it operates global development, manufacturing, and testing facilities serving drug development, clinical trial, and commercial production stages. Core capabilities include mammalian and microbial bioprocessing, viral and plasmid production, small-molecule synthesis, endotoxin and sterility testing, and integrated CDMO services from early development through commercial supply. Founded in 1897, Lonza is publicly listed on the SIX Swiss Exchange and employs over 18,000 people worldwide.